Navigation Links
Neuralstem updates ALS clinical trial progress
Date:10/19/2010

ROCKVILLE, Maryland, October 18, 2010 Neuralstem, Inc. (NYSE Amex: CUR) updated the progress of its ongoing Phase I human clinical trial of the company's spinal cord stem cells in the treatment of ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig's disease) at Emory University in Atlanta, Georgia. The company announced that, after reviewing the safety data from the first six non-ambulatory patients, the trial's Safety Monitoring Board has unanimously approved moving to the next group of ALS patients, all of whom will be ambulatory.

"We are pleased with the progress of the trial to date, and look forward to moving directly into more recently-diagnosed patients," commented Dr. Eva Feldman, PhD, MD, Principal Investigator of the trial and a consultant to Neuralstem. Dr. Feldman is Director of the A. Alfred Taubman Medical Research Institute and Director of Research of the ALS Clinic at the University of Michigan Health System.

"We are encouraged by the Board's approval to advance the trial to patients who have an earlier stage of the disease," said Neuralstem's CEO and president, Richard Garr. "While the primary endpoint of the trial is safety, we also hope to see some secondary endpoints showing efficacy. We are grateful to the patients, and their families, for participating in this trial."

The first six patients treated in the trial were non-ambulatory. Of these, the first three received five injections each, unilaterally, in the lumbar region of the spinal cord. The next three received ten injections each, bilaterally in the lumbar region. All of the remaining patients in the trial will be ambulatory, and therefore represent earlier stages of disease progression. Of the ambulatory group, the first three patients will receive five injections each, unilaterally, in the lumbar region. The next three will receive ten injections each, bilaterally, in the lumbar region. After the required FDA approval, the final six patients in the tri
'/>"/>

Contact: Deanne Eagle
deanneeagle@gmail.com
917-837-5866
Neuralstem, Inc.
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Neuralstem chief scientific officer to take part in World Stem Cell Summit plenary session
2. Neuralstem stem cells survive and differentiate into neurons in rats with stroke
3. Neuralstem files FDA application for first chronic spinal cord injury stem cell trial
4. Neuralstem updates clinical trial progress
5. New "howsthepatient" iPhone App Provides a Simple, Seamless Way to Send Health Updates to Friends and Family
6. FDA Updates Import Alert 71-04 for Salmonella Contaminated Animal Feeds: Many Non-U.S. Firms Affected According to FDAImports.com, LLC
7. Clone Systems, Inc. Updates PCI Solutions for Level 1 & 2 Merchants
8. American Traveler Offers New Healthcare Jobs Hourly, Updates Via Job RSS & Twitter
9. Global Medical Products (GMDP) Selects Mina Mar Group as Its Corporate Advisor And Updates
10. Sunquest Announces Major Software Updates and Enhancements
11. New clinical trial explores role of vitamin D in preventing esophageal cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... City, OK and Seattle, WA (PRWEB) May 04, 2015 ... announced the formation of a collaboration to facilitate development ... number of ophthalmic disorders that lead to blindness, including ... to the MiDROPS™ formulation platform developed by EyeCRO, which ... the eye via a topical eyedrop. , Under ...
(Date:5/4/2015)... NC (PRWEB) May 04, 2015 CCL, ... to offer this unique program to other leadership development ... valuable ties between CCL and successful practitioners, expanding our ... around the globe,” said John R. Ryan, CCL President ... joins the CCL Partner Network , it will ...
(Date:5/4/2015)... 2015 New West Medicare is excited ... LLC to manage outpatient advanced imaging services for its ... ensure its members are provided the right test at ... closely with New West Medicare’s physicians and hospitals, Care ... of advanced imaging and provide an objective basis for ...
(Date:5/4/2015)... Pa. (PRWEB) May 04, 2015 Sylvia Hawthorn-Deppen ... the hopes that it would remind others in similar situations ... A Recovery from Chronic Pain and Discovery of New Energy” ... with a new audience via a renewed press campaign. , ... with debilitating pain ,” Hawthorn-Deppen says. “As an adolescent ...
(Date:5/4/2015)... 04, 2015 Fast on the heels ... Trace Amounts, and Allison Folmar, JD, join over 150 ... internationally. , On Sunday, May 24, the conference presents ... possible?" Are you interested in Ryan Hinds' recovery story? ... our war against autism was written by Marcia ...
Breaking Medicine News(10 mins):Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:Author launches new press campaign for 2012 book ‘Wheel’ 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 2Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 3Health News:Perhaps the most important information families touched by autism will ever hear is available this month at international conference in Chicago 4
... bill granting temporary relief from looming cuts to Medicare ... with millions of patientscontinues to face significant threats to ... "This is good news, and we are ... delay reimbursement cuts to medical imaging," said Michael M. ...
... of Urology opened its 25th Anniversary Congress. During the ... the outstanding work they did for the urological community. ... The EAU Willy Gregoir Medal is the highest ... It was awarded to Prof.,Frans Debruyne (NL) for his ...
... ... to offer strategies for talent development and explore the decision science of workforce analytics, ... Irving, Texas ... solutions, will bring sought-after Human Resources industry speakers Marc Effron, president at The Talent ...
... of life, researchers say , FRIDAY, April 16 (HealthDay News) ... significant improvements in their ability to move their limbs, and ... , The study, by the U.S. Department of Veterans Affairs ... Journal of Medicine , offers the strongest evidence yet that ...
... clock, TeleCare, a home monitoring device, gives the chronically ill ... Researchers from Case Western Reserve University and Cleveland State University ... complex health issues healthy and out of the hospital. ... one-year pilot grant to investigators Elizabeth Madigan from the Frances ...
... ... Wide Format Digital Printing and ID Badge divisions. , ... Memphis, TN (PRWEB) April 16, 2010 -- Memphis-based ... The company’s two distinct product divisions, Wide Format Digital Printing and ID Badge Systems, ...
Cached Medicine News:Health News:SNM applauds temporary freeze on Medicare cuts 2Health News:Talent Management Guru Marc Effron and Workforce Analytics Expert Al Adamsen to Deliver Keynote Speeches at Aquire's Annual User Conference 2Health News:Talent Management Guru Marc Effron and Workforce Analytics Expert Al Adamsen to Deliver Keynote Speeches at Aquire's Annual User Conference 3Health News:Robot-Aided Therapy Can Help Patients Years After Stroke 2Health News:CWRU study examines effectiveness of telemonitoring vital signs 2Health News:LSI Earns 3M Warranty Certification; Gains Federal ID Badge Contracts 2Health News:LSI Earns 3M Warranty Certification; Gains Federal ID Badge Contracts 3
(Date:5/4/2015)... -- FireflySci Inc., the newest member of the cuvette manufacturing world, opened their doors to ... industry on its head by offering scientists amazing support for their spectroscopy needs.  ... ... ... ...
(Date:5/4/2015)... JUPITER, Fla. , May 4, 2015 /PRNewswire/ ... global biotechnology company whose patented and proprietary technologies ... and other proteins for the bioenergy, bio-based chemical, ... it will report its financial results for quarter ... Thursday, May 14, 2015 and will host a ...
(Date:5/4/2015)... -- Intarcia Therapeutics, Inc. today announced ... the newly created role of Chief Operating Officer ... with world-class experience – most recently at Takeda ... industry leaders such as Pfizer and Bristol Myers ... therapeutic areas, including: cardiovascular, metabolic, oncology, neuroscience, gastrointestinal, ...
Breaking Medicine Technology:New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 2New Cuvette Manufacturer Delivers Fast, Easy Solutions for Even the Hardest Cuvette Experiments 3Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 2Dyadic International To Announce First Quarter 2015 Financial Results and Host Conference Call On Thursday, May 14, 2015 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 2Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 3Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S. 4
... Novartis Pharmaceuticals Corporation ("Novartis") announced today that ... Drugs Advisory Committee (ODAC) recommended approval of Afinitor® ... advanced neuroendocrine tumors (NET) of pancreatic origin. ... data from the everolimus RADIANT (RAD001 In Advanced ...
... 12, 2011 MSA (NYSE: MSA ), the ... that protect people,s health and safety, announced today that it ... via the Internet on Thursday, April 28, 2011 at 10:00 ... Investors and interested parties will have the opportunity ...
Cached Medicine Technology:Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10MSA Schedules First Quarter Earnings Webcast 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: